Drug
Restylane L
Restylane L: highest development phase Post-Market, developed by Galderma. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Galderma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Restylane-L® NCT03460158 | Post-Market | Cosmetic Techniques |
Latest
No recent events.
Follow Restylane L on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.